2011•International Journal of Cardiovascular DiseaseRequires access

Effects of atorvastatin on inflammatory level and clinical prognosis in patients with chronic congestive heart failure and paroxysmal atrial fibrillation

Xu Liu

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of atorvastatin on inflammatory level and clinical prognosis in patients with chronic congestive heart failure and paroxysmal atrial fibrillation(AF).Methods:A total of 135 patients with chronic congestive heart failure and paroxysmal AF were divided into atorvastatin group(72 cases) and control group(63 cases).During the 18 months' follow-up,CRP and serum lipid level,left atrial diameter and left ventricular function were measured.In addition,we also evaluated the recurrence of paroxysmal AF and the incidences of persistent and permanent AF,and cardiocerebral vascular events.Results:After atorvastatin treatment,the levels of CRP at 1-month,6-month,18-month were diminished significantly.Lipid levels were also improved markedly in atorvastatin group.During 18-month following-up,the recurrence of paroxysmal AF and incidence of persistent and permanent AF,and cardiocerebral vascular events were decreased in atorvastatin group.Conclusion:Atorvastatin could reduce the CRP level and decrease the recurrence of paroxysmal AF,and incidences of persistent and permanent AF,which also attenuated the cardiocerebral vascular events in follow-up.

About this research paper

What this paper is about

Objective:To investigate the effects of atorvastatin on inflammatory level and clinical prognosis in patients with chronic congestive heart failure and paroxysmal atrial fibrillation(AF).Methods:A total of 135 patients with chronic congestive heart failure and paroxysmal AF were divided into atorvastatin group(72 cases) and control group(63 cases).During the 18 months' follow-up,CRP and serum lipid level,left atrial diameter and left ventricular function were measured.In addition,we also evaluated the recurrence of paroxysmal AF and the incidences of persistent and permanent AF,and cardiocerebral vascular events.Results:After atorvastatin treatment,the levels of CRP at 1-month,6-month,18-month were diminished significantly.Lipid levels were also improved markedly in atorvastatin group.During 18-month following-up,the recurrence of paroxysmal AF and incidence of persistent and permanent AF,and cardiocerebral vascular events were decreased in atorvastatin group.Conclusion:Atorvastatin could reduce the CRP level and decrease the recurrence of paroxysmal AF,and incidences of persistent and permanent AF,which also attenuated the cardiocerebral vascular events in follow-up.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of atorvastatin on inflammatory level and clinical prognosis in patients with chronic congestive heart failure and paroxysmal atrial fibrillation(AF).Methods:A total of 135 patients with chronic congestive heart failure and paroxysmal AF were divided into atorvastatin group(72 cases) and control group(63 cases).During the 18 months' follow-up,CRP and serum lipid level,left atrial diameter and left ventricular function were measured.In addition,we also evaluated the recurrence of paroxysmal AF and the incidences of persistent and permanent AF,and cardiocerebral vascular events.Results:After atorvastatin treatment,the levels of CRP at 1-month,6-month,18-month were diminished significantly.Lipid levels were also improved markedly in atorvastatin group.During 18-month following-up,the recurrence of paroxysmal AF and incidence of persistent and permanent AF,and cardiocerebral vascular events were decreased in atorvastatin group.Conclusion:Atorvastatin could reduce the CRP level and decrease the recurrence of paroxysmal AF,and incidences of persistent and permanent AF,which also attenuated the cardiocerebral vascular events in follow-up.

Key concepts: Medicine, Atorvastatin, Internal medicine, Heart failure, Cardiology, Atrial fibrillation, Incidence (geometry), Paroxysmal atrial fibrillation

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of atorvastatin on inflammatory level and clinical prognosis in patients with chronic congestive heart failure and paroxysmal atrial fibrillation — Research Paper | ScholarLens